Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : Aspen Technology, Johnson & Johnson To Ramp Up COVID-19 Vaccine Production In EU, Africa

09/02/2021 | 04:49am EDT


ę MT Newswires 2021
All news about JOHNSON & JOHNSON
10/15S&P 500 Posts 1.8% Weekly Gain, Strongest Since July, Amid Positive Start to Q3 Results..
MT
10/15JOHNSON & JOHNSON : COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Us..
PR
10/15STREET COLOR : Global Calendar For Week Ending October 22
MT
10/15JOHNSON & JOHNSON : COVID-19 Vaccine Booster Shot Receives FDA Advisory Panel Recommendati..
MT
10/15FDA panel recommends J&J COVID-19 booster for all recipients who got first shot
AQ
10/15JOHNSON & JOHNSON : COVID-19 Vaccine Wins FDA Advisory Panel's Backing as Booster for Adul..
MT
10/15JOHNSON & JOHNSON : Earns a Spot on Fortune's 2021 Change the World List
PU
10/15JOHNSON & JOHNSON : Janssen Gets Positive Opinion on Lung Cancer Treatment From European M..
MT
10/15FDA PANEL BACKS JOHNSON & JOHNSON CO : Bloomberg
MT
10/15CORONAVIRUS : Peace Corps Helps Launch Vaccination Campaign in Commune of Mantasoa The cam..
AQ
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 93 970 M - -
Net income 2021 22 809 M - -
Net cash 2021 2 466 M - -
P/E ratio 2021 18,7x
Yield 2021 2,58%
Capitalization 425 B 425 B -
EV / Sales 2021 4,49x
EV / Sales 2022 4,21x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 161,30 $
Average target price 185,83 $
Spread / Average Target 15,2%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.13.20%232 621
ELI LILLY AND COMPANY40.89%215 657
MERCK & CO., INC.-4.24%198 283